Galantamine-induced improvements in cognitive function are not related to alterations in α4β2 nicotinic receptors in early Alzheimer’s disease as measured in vivo by 2-[18F]Fluoro-A-85380 PET

Julia R. Ellis, Pradeep J. Nathan, Victor L. Villemagne, Rachel S. Mulligan, Timothy Saunder, Kelvin Young, C. Smith, John L. Welch, Mark Woodward, Keith Wesnes,

Psychopharmacology · 2008 · 22 citations · 110 references

Concepts

References

110